Ubs Asset Management Americas Inc Guardant Health, Inc. Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,612,777 shares of GH stock, worth $120 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,612,777

Previous 3,344,037 21.87%

Holding current value

$120 Million

Previous $76.7 Million 4.1%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$20.2 - $38.11 $14.8 Million - $27.9 Million	-731,260 Reduced 21.87%	2,612,777 $79.8 Million
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $2.48 Million - $4.03 Million	110,993 Added 3.43%	3,344,037 $76.7 Million
Q2 2024 Aug 13, 2024	BUY	$16.07 - $31.84 $37.5 Million - $74.2 Million	2,331,011 Added 258.42%	3,233,044 $93.4 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $4.56 Million - $7.16 Million	265,941 Added 41.81%	902,033 $18.6 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $1.07 Million - $1.46 Million	49,643 Added 8.47%	636,092 $17.2 Million
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $7.69 Million - $11.9 Million	298,172 Added 103.43%	586,449 $17.4 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $86,912 - $128,017	3,792 Added 1.33%	288,277 $6.76 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $3.73 Million - $8.78 Million	146,794 Added 106.61%	284,485 $7.74 Million
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $969,208 - $1.35 Million	-22,199 Reduced 13.88%	137,691 $7.41 Million
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $2.34 Million - $6.29 Million	-81,259 Reduced 33.7%	159,890 $6.45 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $2.07 Million - $4.31 Million	-42,884 Reduced 15.1%	241,149 $16 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $3.35 Million - $4.55 Million	37,780 Added 15.34%	284,033 $28.4 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $13.7 Million - $18.4 Million	139,023 Added 129.65%	246,253 $30.8 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $624,810 - $943,050	5,692 Added 5.61%	107,230 $13.3 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $71,269 - $100,475	561 Added 0.56%	101,538 $15.5 Million
Q4 2020 Mar 01, 2021	BUY	$99.96 - $135.93 $3.68 Million - $5 Million	36,796 Added 57.33%	100,977 $13 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $32,288 - $44,943	402 Added 0.63%	64,181 $7.17 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $827,079 - $1.33 Million	13,673 Added 27.29%	63,779 $5.17 Million
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $694,133 - $1.04 Million	11,757 Added 30.66%	50,106 $3.49 Million
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $291,619 - $405,787	-4,902 Reduced 11.33%	38,349 $3 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $1.23 Million - $2.17 Million	19,718 Added 83.79%	43,251 $2.76 Million
Q2 2019 Aug 15, 2019	BUY	$63.94 - $91.11 $1.5 Million - $2.14 Million	23,533 New	23,533 $0

Others Institutions Holding GH

# of Institutions

348

Shares Held

120M

Call Options Held

793K

Put Options Held

1.85M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.71B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Guardant Health, Inc. Transaction History